Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study
-
Altmetric Citations
Davies, Josephine; Lokuge, Kamalini; Glass, Kathryn
Description
Lassa fever is an acute viral illness caused by Lassa virus (LASV), a rodent-borne pathogen. LASV is endemic to much of Sub-Saharan West Africa, where seasonal outbreaks cause significant morbidity and mortality. Increased global awareness of LASV has led to development of improved diagnostic tests, treatments and vaccines. As vaccine candidates are trialled, it is essential to assess the potential outcomes of introducing a LASV vaccination program in endemic regions. This study investigates...[Show more]
dc.contributor.author | Davies, Josephine | |
---|---|---|
dc.contributor.author | Lokuge, Kamalini | |
dc.contributor.author | Glass, Kathryn | |
dc.date.accessioned | 2020-01-02T03:40:44Z | |
dc.identifier.issn | 0264-410X | |
dc.identifier.uri | http://hdl.handle.net/1885/196461 | |
dc.description.abstract | Lassa fever is an acute viral illness caused by Lassa virus (LASV), a rodent-borne pathogen. LASV is endemic to much of Sub-Saharan West Africa, where seasonal outbreaks cause significant morbidity and mortality. Increased global awareness of LASV has led to development of improved diagnostic tests, treatments and vaccines. As vaccine candidates are trialled, it is essential to assess the potential outcomes of introducing a LASV vaccination program in endemic regions. This study investigates the potential outcomes of routine and pulse vaccination strategies using a deterministic mathematical model that captures seasonal LASV transmission between rodents and humans. For plausible parameter values, we find that immunization of 40% of infants at 70% vaccine effectiveness achieves a population-level reduction in infectious case numbers of 30%, while coverage of 60% at 90% vaccine effectiveness achieves a 56% reduction. Similar reductions can be achieved more rapidly via population-wide pulse vaccination at 11% coverage (30% reduction at 70% effectiveness) or 23% coverage (56% reduction at 90% effectiveness) repeated every 10 years. Similar pulse vaccine doses delivered at reduced frequency, but increased coverage achieves a greater reduction in infectious cases. Findings around infant vaccination are sensitive to our assumption that immunity is life-long, while pulse-vaccination has only slightly reduced effect if immunity lasts 10–30 years. An effective LASV vaccination program would incorporate pulse vaccination in addition to routine childhood immunization to limit disease. Estimates of feasible vaccine coverage and effectiveness are needed to fully quantify the likely benefits of a vaccination program in LASV endemic regions. | |
dc.format.mimetype | application/pdf | |
dc.language.iso | en_AU | |
dc.publisher | Elsevier | |
dc.rights | Crown Copyright © 2019 Published by Elsevier Ltd. | |
dc.source | Vaccine | |
dc.title | Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study | |
dc.type | Journal article | |
local.description.notes | Imported from ARIES | |
local.identifier.citationvolume | 37 | |
dc.date.issued | 2019 | |
local.identifier.absfor | 111799 - Public Health and Health Services not elsewhere classified | |
local.identifier.absfor | 010299 - Applied Mathematics not elsewhere classified | |
local.identifier.ariespublication | u5234101xPUB266 | |
local.publisher.url | https://www.elsevier.com/en-au | |
local.type.status | Published Version | |
local.contributor.affiliation | Davies, Josephine, College of Health and Medicine, ANU | |
local.contributor.affiliation | Lokuge, Kamalini, College of Health and Medicine, ANU | |
local.contributor.affiliation | Glass, Kathryn, College of Health and Medicine, ANU | |
local.description.embargo | 2037-12-31 | |
local.bibliographicCitation.issue | 26 | |
local.bibliographicCitation.startpage | 3451 | |
local.bibliographicCitation.lastpage | 3456 | |
local.identifier.doi | 10.1016/j.vaccine.2019.05.010 | |
local.identifier.absseo | 920499 - Public Health (excl. Specific Population Health) not elsewhere classified | |
local.identifier.absseo | 920404 - Disease Distribution and Transmission (incl. Surveillance and Response) | |
local.identifier.absseo | 920412 - Preventive Medicine | |
dc.date.updated | 2019-08-04T08:21:35Z | |
Collections | ANU Research Publications |
Download
File | Description | Size | Format | Image |
---|---|---|---|---|
01_Davies_Routine_and_pulse_vaccination_2019.pdf | 871.24 kB | Adobe PDF | Request a copy |
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.
Updated: 17 November 2022/ Responsible Officer: University Librarian/ Page Contact: Library Systems & Web Coordinator